DIA Canada Annual Meeting Call for Topics: Submission Form

Welcome to our 2022 Canada Annual Meeting Call for Topics brainstorming activity!!

By brainstorming together, we aim to gain a better understanding of your professional needs and the type of content we should focus on for the DIA Canada Annual Meeting program agenda. Please note: submission of a topic suggestion is not related to chairing a session or speaking at the Canada Annual Meeting. What topic(s) would you like to see at DIA’s Canada Annual Meeting in 2022?

Question Title

* Please select the topic(s) you would be interested in hearing about at the conference (select all that apply). If something is not listed, please add to the “other” field:

Health Canada’s Regulatory Information Agenda

International work-sharing initiatives and collaborations

Use of foreign reviews/decisions to support drug submissions

Early Scientific advice from stakeholders in drug access

Pathways used by other regulatory jurisdictions (advantages and challenges)

Regulatory Health Authority and Health Technology Assessment (HTA) reviews (challenges, opportunities, and lessons learned)

Strengthening the sharing and use of Real-World Data/Real World Evidence

Biologics/biosimilars

Generic drugs/Canadian reference products

Advanced therapeutic products (ATPs)

Opioids

Regulatory Considerations and Perspectives on RWD and RWE

Environmental assessment regulations

Patented medicine prices review board

Medical Devices (challenges and opportunities)

Adaptive clinical trial design - application and effect on product lifecycle

How to appropriately choose endpoints that will meet regulator’s, payers’, Health Technology Assessment’s needs

Surrogate endpoints

Use of Real-World Data in clinical trial design and research

Novel approaches in clinical trial recruitment

Clinical trial data transparency

Wearables in clinical trials

Artificial intelligence and/or machine learning in clinical research

Post-market studies

Inspections

Remote monitoring

General topics on DEI in relation to life sciences R&D

General topics on patient engagement, the patient voice and patient care in relation to life sciences R&D

How to effectively collaborate and engage in policy, including collaborating with Health Canada

How to critically review draft health authority guidance documents

Cannabis

Screenings for diseases

Biomarker use in clinical trials

Genetic testing

Gene editing

Best practices for social media use in patient engagement — compliance, legal, regulatory, and medical considerations

Promotion and advertising in social media

How to incorporate the patient voice – addressing the growing number of patient entry databases

Digital health

Artificial Intelligence

Emerging technologies

Risk communication

Risk minimization measures

Crisis management

GVP Inspections

Other Topics (Please note - the suggestion may not exceed 300 characters)